Alliance Global signs exclusive distribution agreement with SignalChem

July, 2020 – SignalChem a leading manufacturer in protein engineering, manufacturing, purification and assay development has signed an exclusive distribution agreement with Alliance Global (AGBL Group) to market the range of innovative and high-quality human recombinant cell signalling products.

The highly active enzymes, including protein kinases, disease-related mutant kinases, lipid kinases, epigenetic enzymes, ubiquitination-related enzymes, and neurodegenerative disease-related enzymes and proteins, provide effective research tools for life science research and also facilitate the efforts in drug discovery and development.